Spero Therapeutics Inc (SPRO)
Spero Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 26, 2026
Spero Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 26, 2026
agilon health - agilon health Announces Reverse Stock Split
Spectral AI Awarded $31.7 Million of BARDA Funding to Accelerate Development of the DeepView® System
4DMT Reports Full Year 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones
Zeo Energy To Attend 38th Annual ROTH Conference
IGI Announces Changes to its Board of Directors
Swarmer Announces Closing of Initial Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Spero Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 26, 2026
INVESTOR ALERT: monday.com Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)